Jim Simons Volitionrx LTD Transaction History

Renaissance Technologies LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.41 - $3.24 $27,233 - $36,612	-11,300 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$3.02 - $4.13 $354,548 - $484,862	-117,400 Reduced 91.22%	11,300 $35,000
Q3 2021 Nov 12, 2021	SELL	$2.98 - $3.48 $351,392 - $410,351	-117,917 Reduced 47.81%	128,700 $399,000
Q2 2021 Aug 13, 2021	BUY	$3.01 - $3.78 $652,017 - $818,812	216,617 Added 722.06%	246,617 $811,000
Q1 2021 May 13, 2021	BUY	$3.33 - $6.5 $99,900 - $195,000	30,000 New	30,000 $113,000
Q3 2020 Nov 13, 2020	SELL	$2.94 - $4.05 $84,607 - $116,550	-28,778 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$2.89 - $4.32 $83,168 - $124,320	28,778 New	28,778 $112,000
Q1 2020 May 14, 2020	SELL	$2.47 - $5.16 $129,181 - $269,868	-52,300 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$4.28 - $5.95 $63,772 - $88,655	-14,900 Reduced 22.17%	52,300 $248,000
Q3 2019 Nov 13, 2019	BUY	$2.97 - $6.42 $149,391 - $322,926	50,300 Added 297.63%	67,200 $378,000
Q2 2019 Aug 12, 2019	BUY	$2.93 - $3.6 $16,115 - $19,800	5,500 Added 48.25%	16,900 $53,000
Q1 2019 May 14, 2019	BUY	$2.19 - $3.45 $24,966 - $39,330	11,400 New	11,400 $37,000

8.17M

53.6K

300

Ticker VNRX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 57,297,000
Market Cap $33.2M
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.